Literature DB >> 24722312

Brain structure and function in patients after metal-on-metal hip resurfacing.

M J Clark1, J R Prentice1, N Hoggard2, M N Paley2, M Hadjivassiliou3, J M Wilkinson4.   

Abstract

BACKGROUND AND
PURPOSE: Hip prostheses that use a metal-on-metal articulation expose the brain to elevated metal concentrations that, in acute excess due to prosthesis malfunction, is associated with neurologic damage, including visual and hearing loss and motor deficits. Here, we examined whether chronic exposure to lower elevated metal levels, typical of well-functioning prostheses, also affects brain structure and function.
MATERIALS AND METHODS: We compared brain volumes, metal deposition, and gray matter attenuation by MR imaging and clinical neurologic function in patients 8 years after receiving a metal-on-metal hip resurfacing versus a matched group of patients with the same duration exposure to a conventional hip prosthesis.
RESULTS: Twenty-nine patients (25 men; mean, age 59±7 years) after metal-on-metal hip resurfacing and 29 patients (25 men; 59±8 years) after total hip arthroplasty were compared. Whole blood cobalt and chromium concentrations were 5-10 times higher in the metal-on-metal hip resurfacing group (P<.0001). Occipital cortex gray matter attenuation tended to be lower (P<.005 uncorrected, P>.05 corrected), and the optic chiasm area tended to be lower (mean difference, -2.7 mm2; P=.076) in the metal-on-metal hip resurfacing group. Subgroup analyses in 34 patients (17 per group), after exclusion of primary ocular pathology, showed the same trend in gray matter attenuation in the occipital cortex and basal ganglia and a smaller optic chiasm in the metal-on-metal hip resurfacing group (mean difference, -3.9 mm2; P=.048). No other structural or functional differences were found between the groups.
CONCLUSIONS: Chronic exposure to metal-on-metal hip resurfacing is associated with subtle structural change in the visual pathways and the basal ganglia in asymptomatic patients.
© 2014 by American Journal of Neuroradiology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24722312      PMCID: PMC7966284          DOI: 10.3174/ajnr.A3922

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  40 in total

1.  Delays and difficulties in assessing metal-on-metal hip implants.

Authors:  Joshua P Rising; Ian S Reynolds; Art Sedrakyan
Journal:  N Engl J Med       Date:  2012-06-20       Impact factor: 91.245

2.  Dose-effect relationships between manganese exposure and neurological, neuropsychological and pulmonary function in confined space bridge welders.

Authors:  Rosemarie M Bowler; Harry A Roels; Sanae Nakagawa; Marija Drezgic; Emily Diamond; Robert Park; William Koller; Russell P Bowler; Donna Mergler; Maryse Bouchard; Donald Smith; Roberto Gwiazda; Richard L Doty
Journal:  Occup Environ Med       Date:  2006-10-03       Impact factor: 4.402

3.  Ten-year clinical, radiological and metal ion analysis of the Birmingham Hip Resurfacing: from a single, non-designer surgeon.

Authors:  J P Holland; D J Langton; M Hashmi
Journal:  J Bone Joint Surg Br       Date:  2012-04

4.  In vivo and in vitro effects of chromium VI on anterior pituitary hormone release and cell viability.

Authors:  Fernanda A Quinteros; Ariel H B Poliandri; Leticia I Machiavelli; Jimena P Cabilla; Beatriz H Duvilanski
Journal:  Toxicol Appl Pharmacol       Date:  2006-10-27       Impact factor: 4.219

5.  The measurement of R2, R2* and R2' in HIV-infected patients using the prime sequence as a measure of brain iron deposition.

Authors:  K A Miszkiel; M N Paley; I D Wilkinson; M A Hall-Craggs; R Ordidge; B E Kendall; R F Miller; M J Harrison
Journal:  Magn Reson Imaging       Date:  1997       Impact factor: 2.546

6.  Thalamic atrophy associated with painful osteoarthritis of the hip is reversible after arthroplasty: a longitudinal voxel-based morphometric study.

Authors:  Stephen E Gwilym; Nicola Filippini; Gwenaelle Douaud; Andrew J Carr; Irene Tracey
Journal:  Arthritis Rheum       Date:  2010-10

7.  MRI assessment of basal ganglia iron deposition in Parkinson's disease.

Authors:  Lauren I Wallis; Martyn N J Paley; Jacqueline M Graham; Richard A Grünewald; Emma L Wignall; Harriet M Joy; Paul D Griffiths
Journal:  J Magn Reson Imaging       Date:  2008-11       Impact factor: 4.813

Review 8.  Fast robust automated brain extraction.

Authors:  Stephen M Smith
Journal:  Hum Brain Mapp       Date:  2002-11       Impact factor: 5.038

9.  Pitfalls in the use of voxel-based morphometry as a biomarker: examples from huntington disease.

Authors:  S M D Henley; G R Ridgway; R I Scahill; S Klöppel; S J Tabrizi; N C Fox; J Kassubek
Journal:  AJNR Am J Neuroradiol       Date:  2009-12-24       Impact factor: 3.825

10.  Strongly reduced volumes of putamen and thalamus in Alzheimer's disease: an MRI study.

Authors:  L W de Jong; K van der Hiele; I M Veer; J J Houwing; R G J Westendorp; E L E M Bollen; P W de Bruin; H A M Middelkoop; M A van Buchem; J van der Grond
Journal:  Brain       Date:  2008-11-20       Impact factor: 13.501

View more
  15 in total

1.  Environmental Presence of Hexavalent but Not Trivalent Chromium Causes Neurotoxicity in Exposed Drosophila melanogaster.

Authors:  Pallavi Singh; D Kar Chowdhuri
Journal:  Mol Neurobiol       Date:  2016-05-11       Impact factor: 5.590

2.  Self-reported systemic complaints in patients with metal-on-metal hip arthroplasty.

Authors:  Jetse Jelsma; Martijn Schotanus; Henne Kleinveld; Bernd Grimm; Ide Heyligers
Journal:  J Orthop       Date:  2020-01-25

Review 3.  Hair, serum and urine chromium levels in children with cognitive defects: A systematic review and meta-analysis of case control studies.

Authors:  G M Rabiul Islam; Mohammad Meshbahur Rahman; Mohammed Imrul Hasan; Amare Worku Tadesse; Jena Derakhshani Hamadani; Davidson H Hamer
Journal:  Chemosphere       Date:  2021-11-20       Impact factor: 7.086

Review 4.  Current understanding of hexavalent chromium [Cr(VI)] neurotoxicity and new perspectives.

Authors:  John P Wise; Jamie L Young; Jun Cai; Lu Cai
Journal:  Environ Int       Date:  2021-09-20       Impact factor: 9.621

5.  Trace Element Changes in the Plasma of Autism Spectrum Disorder Children and the Positive Correlation Between Chromium and Vanadium.

Authors:  Jun Zhang; Jing Lin; Xiying Zhao; Fang Yao; Chengyun Feng; Zhijun He; Xueshan Cao; Yan Gao; Naseer Ullah Khan; Margy Chen; Peng Luo; Liming Shen
Journal:  Biol Trace Elem Res       Date:  2022-01-10       Impact factor: 4.081

6.  Neuropsychiatric symptoms following metal-on-metal implant failure with cobalt and chromium toxicity.

Authors:  Ben Green; Emily Griffiths; Solomon Almond
Journal:  BMC Psychiatry       Date:  2017-01-24       Impact factor: 3.630

7.  Reproductive outcomes after non-occupational exposure to hexavalent chromium, Willits California, 1983-2014.

Authors:  Linda L Remy; Vera Byers; Ted Clay
Journal:  Environ Health       Date:  2017-03-06       Impact factor: 5.984

Review 8.  The contribution of the histopathological examination to the diagnosis of adverse local tissue reactions in arthroplasty.

Authors:  Giorgio Perino; Ivan De Martino; Lingxin Zhang; Zhidao Xia; Jiri Gallo; Shonali Natu; David Langton; Monika Huber; Anastasia Rakow; Janosch Schoon; Enrique Gomez-Barrena; Veit Krenn
Journal:  EFORT Open Rev       Date:  2021-06-28

9.  Auditory and visual health after ten years of exposure to metal-on-metal hip prostheses: a cross-sectional study follow up.

Authors:  Jennifer R Prentice; Christopher S Blackwell; Naz Raoof; Paul Bacon; Jaydip Ray; Simon J Hickman; J Mark Wilkinson
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240

Review 10.  Increased Mortality in Metal-on-Metal versus Non-Metal-on-Metal Primary Total Hip Arthroplasty at 10 Years and Longer Follow-Up: A Systematic Review and Meta-Analysis.

Authors:  B G Pijls; J M T A Meessen; J W Schoones; M Fiocco; H J L van der Heide; A Sedrakyan; R G H H Nelissen
Journal:  PLoS One       Date:  2016-06-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.